SNN Smith & Nephew plc

SNN expands its trauma portfolio with the EVOS PELVIC System, targeting complex pelvic and acetabular fracture procedures in the United States.

The latest analyst work on S.N. Nuclearelectrica centers on a revised price target of RON 49.75, up from RON 44.80. This sets a new reference point for how the stock is being valued. This change reflects a mix of optimism and caution in recent commentary, with research tying the new target to refreshed assumptions rather than a single event. As you read on, you will see how this evolving narrative might shape the way you track S.N. Nuclearelectrica from here. Stay updated as the Fair Value...

European equities traded in the US as American depositary receipts were rising sharply late Thursday

European equities traded in the US as American depositary receipts opened the week tracking sharply

Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and supply chain.

European equities traded in the US as American depositary receipts were marginally higher late Frida

European equities traded in the US as American depositary receipts were marginally higher late Tuesd

John Rogers, who has experience leading change at companies, is expected to help Baxter’s turnaround gain traction. He joins Baxter after the company sold two business units.

Smith+Nephew's five-year Imperial College London partnership targets less invasive robotic surgery and could speed research into clinical use.

European equities traded in the US as American depositary receipts were tracking higher late Wednesd

8.44am: Inflation may not move Bank of England dial Some thoughts on this morning's UK inflation numbers, which showed July's CPI up 2.9% from a year ago, increasing from 2.6% in June. Core CPI stayed put at 2.6%, while services CPI slowed to 3.4% from 3.6%. "What happened in July?...

SNN launches the FLOW FLEXTEND COBLATION Wand, offering adjustable-angle access and precise tissue removal in complex joint procedures.

Moby summary of Spectral AI, Inc.'s Q2 2026 earnings call

Smith & Nephew SNATS (NYSE:SNN) reported second-quarter underlying revenue growth of 1.6%, below management’s expectations, as continued strength in Sports Medicine and ENT was offset by weakness in U.S. Orthopaedics and Advanced Wound Bioactives. Chief Executive Officer Deepak Nath said quarte

European equities traded in the US as American depositary receipts were heading higher late Thursday

Nath addresses Orthopaedics gaps and skin substitute headwinds.

European equities traded in the US as American depositary receipts rose late Tuesday morning with th